Three large studies on the use of aspirin to prevent heart attacks, strokes or dementia have now shown no benefit in patients without known cardiovascular disease.
The incidence of significant bleeding was higher in the group taking aspirin compared to the placebo group, without any benefit over almost 5 years.
This negative finding in the primary prevention of vascular disease in those without CVD is a new finding and goes against the previous general recommendation, not previously backed up by evidence.
Several studies have shown that those with cardiovascular disease (CVD) do benefit from the use of 81mg of aspirin on a daily basis, but these 3 studies show that in a general population without CVD, more harm than benefit is the bottomline.www.thenyheartcenter.com
No comments:
Post a Comment